Combined Immunosuppression for Pediatric Crohn's Disease
Status:
Not yet recruiting
Trial end date:
2025-07-01
Target enrollment:
Participant gender:
Summary
This is a randomized controlled trial to compare the efficacy and safety of infliximab and
immunosuppressives therapy alone or in combination for pediatric Crohn's disease.